Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in M3 muscarinic acetylcholine receptor-deficient mice

Diabetes

Volumn 53, Issue 7, 2004, Pages 1714-1720

  Duttaroy, Alokesh ^a,c   Zimliki, Charles L ^b   Gautam, Dinesh ^a   Cui, Yinghong ^a   Mears, David ^b   Wess, Jürgen ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; GLUCOSE; MUSCARINIC AGENT; MUSCARINIC M3 RECEPTOR; OXOTREMORINE; RECEPTOR SUBTYPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC STIMULATION; CONTROLLED STUDY; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCOSE TOLERANCE; HYPOPHAGIA; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; LEAN BODY WEIGHT; METABOLIC REGULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; BLOOD GLUCOSE; GLUCAGON; INSULIN; MICE; MICE, KNOCKOUT; MUSCARINIC AGONISTS; OXOTREMORINE; PANCREAS; RECEPTOR, MUSCARINIC M3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 3042785985     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.7.1714     Document Type: Article

References (36)

1. Kahn SE: Clinical review 135: the importance of beta-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86:4047-4058, 2001
2. Kahn CR: Banting Lecture: insulin action, diabetogenes, and the cause of type 2 diabetes. Diabetes 43:1066-1084, 1994
3. Moller DE: New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414:821-827, 2001
4. Satin LS, Kinard TA: Neurotransmitters and their receptors in the islets of Langerhans of the pancreas: what messages do acetylcholine, glutamate, and GABA transmit? Endocrine 8:213-223, 1998
5. Ahren B: Autonomic regulation of islet hormone secretion: implications for health and disease. Diabetologia 43:393-410, 2000
6. Gilon P, Henquin JC: Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocr Rev 22:565-604, 2001
7. Ahren B, Lundquist I: Modulation of basal insulin secretion in the obese, hyperglycemic mouse. Metabolism 31:172-179, 1982
8. Jeanrenaud B: An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause. Diabetologia 28:502-513, 1985
9. Rohner-Jeanrenaud F, Jeanrenaud B: Involvement of the cholinergic system in insulin and glucagon oversecretion of genetic preobesity. Endocrinology 116:830-834, 1985
10. Fukudo S, Virnelli S, Kuhn CM, Cochrane C, Feinglos MN, Surwit RS: Muscarinic stimulation and antagonism and glucoregulation in nondiabetic and obese hyperglycemic mice. Diabetes 38:1433-1438, 1989
11. Ahren B, Simonsson E, Scheurink AJ, Mulder H, Myrsen U, Sundler F: Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL/6J mice. Metabolism 46:97-106, 1997
12. Edvell A, Lindstrom P: Vagotomy in young obese hyperglycemic mice: effects on syndrome development and islet proliferation. Am J Physiol 274:E1034-E1039, 1998
13. Bloom SR, Edwards AV: Pancreatic endocrine responses to stimulation of the peripheral ends of the vagus nerves in conscious calves. J Physiol 315:31-41, 1981
14. Bergman RN, Miller RE: Direct enhancement of insulin secretion by vagal stimulation of the isolated pancreas. Am J Physiot 225:481-486, 1973
15. Bloom SR, Edwards AV: Effects of certain metabolites on pancreatic endocrine responses to stimulation of the vagus nerves in conscious calves. J Physiol 362:303-310, 1985
16. Honey RN, Weir GC: Acetylcholine stimulates insulin, glucagon, and somatostatin release in the perfused chicken pancreas. Endocrinology 107:1065-1068, 1980
17. Holst JJ, Schaffalitzky de Muckadell OB, Fahrenkrug J, Lindkaer S, Nielsen OV, Schwartz TW: Nervous control of pancreatic endocrine secretion in pigs. III. The effect of acetylcholine on the pancreatic secretion of insulin and glucagon. Acta Physiol Scand 111:15-22, 1981
18. Garcia MC, Hermans MP, Henquin JC: Glucose-, calcium- and concentration-dependence of acetylcholine stimulation of insulin release and ionic fluxes in mouse islets. Biochem J 254:211-218, 1988
19. Persaud SJ, Jones PM, Sugden D, Howell SL: The role of protein kinase C in cholinergic stimulation of insulin secretion from rat islets of Langerhans. Biochem J 264:753-758, 1989
20. Zawalich WS, Zawalich KC, Rasmussen H: Cholinergic agonists prime the beta-cell to glucose stimulation. Endocrinology 125:2400-2406, 1989
21. Verchere CB, Kwok YN, Brown JC: Modulation of acetylcholine-stimulated insulin release by glucose and gastric inhibitory polypeptide. Pharmacology 42:273-282, 1991
22. Wess J: Molecular biology of muscarinic acetylcholine receptors. Crit Rev Neurobiol 10:69-99, 1996
23. 3 muscarinic receptors. Am J Physiol 268: E336-E342, 1995
24. Tang SH, Sharp GW: Identification of muscarinic receptor subtypes in RINm5F cells by means of polymerase chain reaction, subcloning, and DNA sequencing. Diabetes 46:1419-1423, 1997
25. Iismaa TP, Kerr EA, Wilson JR, Carpenter L, Sims N, Biden TJ: Quantitative and functional characterization of muscarinic receptor subtypes in insulin-secreting cell lines and rat pancreatic islets. Diabetes 49:392-398, 2000
26. Verspohl EJ, Tacke R, Mutschler E, Lambrecht G: Muscarinic receptor subtypes in rat pancreatic islets: binding and functional studies. Eur J Pharmacol 178:303-311, 1990
27. Karlsson S, Ahren BJ: Muscarinic receptor subtypes in carbachol-stimulated insulin and glucagon secretion in the mouse. J Auton Pharmacol 13:439-446, 1993
28. Brunicardi FC, Shavelle DM, Andersen DK: Neural regulation of the endocrine pancreas. Int J Pancreatol 18:177-195, 1995
29. Yamada M, Miyakawa T, Duttaroy A, Yamanaka A, Moriguchi T, Makita R, Ogawa M, Chou CJ, Xia B, Crawley JN, Felder CC, Den CX, Wess J: Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 410:207-212, 2001
30. Davalli AM, Ogawa Y, Scaglia L, Wu YJ, Hollister J, Bonner-Weir S, Weir GC: Function, mass, and replication of porcine and rat islets transplanted into diabetic nude mice. Diabetes 44:104-111, 1995
31. Levey AI: Immunological localization of M1-M5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sci 52:441-448, 1993
32. Henquin JC, Nenquin M: The muscarinic receptor subtype in mouse pancreatic B-cells. FEBS Lett 236:89-92, 1988
33. Caulfield MP, Birdsall NJ: International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol Rev 50:279-290, 1998
34. Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR: Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J Pharmacol Exp Ther 256:727-733, 1991
35. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin D: Central nervous system control of food intake. Nature 404:661-671, 2000
36. Hoffman BB, Taylor P: The autonomic and somatic motor nervous systems. In Goodman & Gilman's The Pharmacological Basis of Therapeutics. 10th ed. Hardman JG, Limbird LE, Eds. New York, McGraw-Hill, 2001, p. 115-153